| Literature DB >> 29914471 |
Peter D Karp1, Daniel Weaver2, Mario Latendresse2.
Abstract
BACKGROUND: Reaction gap filling is a computational technique for proposing the addition of reactions to genome-scale metabolic models to permit those models to run correctly. Gap filling completes what are otherwise incomplete models that lack fully connected metabolic networks. The models are incomplete because they are derived from annotated genomes in which not all enzymes have been identified. Here we compare the results of applying an automated likelihood-based gap filler within the Pathway Tools software with the results of manually gap filling the same metabolic model. Both gap-filling exercises were applied to the same genome-derived qualitative metabolic reconstruction for Bifidobacterium longum subsp. longum JCM 1217, and to the same modeling conditions - anaerobic growth under four nutrients producing 53 biomass metabolites.Entities:
Keywords: Evaluation; FBA; Flux balance analysis; Gap-filling
Mesh:
Year: 2018 PMID: 29914471 PMCID: PMC6006690 DOI: 10.1186/s12918-018-0593-7
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
Biomass metabolites defined for the B. longum model. An “X” in column 3 identifies metabolites that could be produced by the model before gap filling was performed
| Name | BioCyc ID | Pre gap fill? |
|---|---|---|
| (2E,6E)-farnesyl diphosphate | FARNESYL-PP | |
| 1-deoxy-D-xylulose 5-phosphate | DEOXYXYLULOSE-5P | |
| 2-C-methyl-D-erythritol 4-phosphate | 2-C-METHYL-D-ERYTHRITOL-4-PHOSPHATE | |
| 2-C-methyl-D-erythritol-2,4-cyclodiphosphate | 2C-METH-D-ERYTHRITOL-CYCLODIPHOSPHATE | |
| 2-phospho-4-(cytidine 5’-diphospho)-2-C-methyl-D-erythritol | 2-PHOSPHO-4-CYTIDINE-5-DIPHOSPHO-2-C-MET | |
| ADP | ADP | X |
| ADP-alpha-D-glucose | ADP-D-GLUCOSE | X |
| AMP | AMP | X |
| ATP | ATP | X |
| CDP-1,2-dipalmitoylglycerol | CPD-12815 | |
| CTP | CTP | |
| GMP | GMP | X |
| GTP | GTP | X |
| H+ | PROTON | X |
| H2O | WATER | X |
| L-alanine | L-ALPHA-ALANINE | |
| L-arginine | ARG | |
| L-asparagine | ASN | |
| L-aspartate | L-ASPARTATE | |
| L-cysteine | CYS | |
| L-glutamate | GLT | |
| L-glutamine | GLN | |
| L-histidine | HIS | |
| L-isoleucine | ILE | |
| L-leucine | LEU | |
| L-lysine | LYS | |
| L-methionine | MET | |
| L-phenylalanine | PHE | |
| L-proline | PRO | |
| L-serine | SER | |
| L-threonine | THR | |
| L-tryptophan | TRP | |
| L-tyrosine | TYR | |
| L-valine | VAL | |
| NAD+ | NAD | X |
| NADH | NADH | X |
| NADP+ | NADP | X |
| NADPH | NADPH | X |
| S-adenosyl-L-methionine | S-ADENOSYLMETHIONINE | X |
| UDP-N-acetyl-alpha-D-glucosamine | UDP-N-ACETYL-D-GLUCOSAMINE | |
| C1 | C1 | |
| UTP | UTP | |
| chorismate | CHORISMATE | X |
| dATP | DATP | |
| dCTP | DCTP | |
| dGTP | DGTP | |
| dTTP | TTP | |
| di-trans,octa-cis-undecaprenyl diphosphate | UNDECAPRENYL-DIPHOSPHATE | |
| dipalmitoyl phosphatidate | CPD0-1422 | |
| C6 | C6 | |
| glycine | GLY | |
| isopentenyl diphosphate | DELTA3-ISOPENTENYL-PP | |
| phosphate | Pi | X |
C1 = UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine. C6 = ditrans,octacis-undecaprenyldiphospho-N-acetyl-(N-acetylglucosaminyl)muramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine
Reactions added to the model by the automated gap filler GenDev (marked “A” in the last column) and by manual gap filling (marked “M” in the last column). Reactions marked “*” in the last column are excess reactions predicted by GenDev that are not in fact needed for growth of the model
| BioCyc Reaction ID | Reaction | Added By |
|---|---|---|
| ASNSYNA-RXN | L-aspartate + ammonium + ATP →L-asparagine + AMP + PPi + H+ | A |
| RXN-1381 | palmitoyl-CoA + sn-glycerol 3-phosphate → | A |
| 1-palmitoylglycerol 3-phosphate + coenzyme A | ||
| DUDPKIN-RXN | dUDP + ATP →dUTP + ADP | A,* |
| CDPKIN-RXN | CDP + ATP →CTP + ADP | A,* |
| DTDPKIN-RXN | dTDP + ATP →dTTP + ADP | A,M |
| UDPKIN-RXN | UDP + ATP →UTP + ADP | A,M |
| GPPSYN-RXN | dimethylallyl diphosphate + isopentenyl diphosphate → | A,M |
| geranyl diphosphate + diphosphate | ||
| FPPSYN-RXN | geranyl diphosphate + isopentenyl diphosphate → | A,M |
| (2E,6E)-farnesyl diphosphate + diphosphate | ||
| RXN-8999 | (2E,6E)-farnesyl diphosphate + 8 isopentenyl diphosphate → | A,M |
| di-trans,octa-cis-undecaprenyl diphosphate + 8 diphosphate | ||
| IGPSYN-RXN | 1-(o-carboxyphenylamino)-1’-deoxyribulose 5’-phosphate + H+ → | A,M |
| (1S,2R)-1-C-(indole-3-yl)glycerol 3-phosphate + CO2 + H2O | ||
| HISTIDPHOS-RXN | L-histidinol-phosphate + H2O →histidinol + phosphate | A,M |
| PREPHENATE-TRANSAMINE-RXN | L-arogenate + 2-oxoglutarate →prephenate + L-glutamate | A,M |
| RXN-12460 | an L-asparaginyl-[tRNAasn] + H2O →L-asparagine + tRNAasn + H+ | M |
| GDPKIN-RXN | GDP + ATP →GTP + ADP | M |
| GLUCOKIN-RXN | D-glucopyranose + ATP →D-glucopyranose 6-phosphate + ADP + H+ | M |
| RXN-17018 | a palmitoyl-[acp] + sn-glycerol 3-phosphate → | M |
| 1-palmitoylglycerol 3-phosphate + a holo-[acyl-carrier protein] | ||
| RXN-17897 | 2 an oxidized ferredoxin [iron-sulfur] cluster + NADPH → | M |
| 2 a reduced ferredoxin [iron-sulfur] cluster + NADP+ + H+ |
Additional discussed reactions
| BioCyc Reaction ID | Reaction |
|---|---|
| ISPH2-RXN | isopentenyl diphosphate + 2 oxidized ferredoxin [iron-sulfur] cluster + H2O → |
| (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate + 2 reduced ferredoxin [iron-sulfur] | |
| cluster + H+ | |
| RXN0-882 | (E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate + 2 oxidized ferredoxin [iron-sulfur] |
| cluster + H2O → | |
| 2-C-methyl-D-erythritol-2,4-cyclodiphosphate + 2 reduced ferredoxin [iron-sulfur] | |
| cluster + H+ | |
| RXN0-302 | 2-phospho-4-(cytidine 5’-diphospho)-2-C-methyl-D-erythritol →2-C-methyl-D-erythritol- |
| 2,4-cyclodiphosphate + CMP |
B. longum and MetaCyc reactions whose directionality was manually curated during B. longum model development. Reaction identifiers can be mapped to actual reactions at the MetaCyc.org website
| BioCyc Reaction ID | Metabolic Goal | Curated Direction |
|---|---|---|
| METHENYLTHFCYCLOHYDRO-RXN | Glycine and one-carbon metabolism | REVERSIBLE |
| HYPOXANPRIBOSYLTRAN-RXN | Histidine synthesis | PHYSIOL-R2L (PPi produced) |
| IMP-DEHYDROG-RXN | Xanthine synthesis | REVERSIBLE |
| RIBOKIN-RXN | Ribose synthesis | PHYSIOL-L2R (kinase activity) |
| RXN-14223 | Ribose degradation | PHYSIOL-L2R |
| TYROSINE-AMINOTRANSFERASE-RXN | Tyrosine synthesis | REVERSIBLE (aminotransferase activity) |
| GLYC3PDEHYDROGBIOSYN-RXN | Phospholipid synthesis | PHYSIOL-R2L (avoid spontaneous |
| NADH → NADPH transhydrogenation) | ||
| 1.1.1.8-RXN | Phospholipid synthesis | PHYSIOL-R2L (avoid spontaneous |
| NADH → NADPH transhydrogenation) | ||
| MALONYL-COA-ACP-TRANSACYL-RXN | Phospholipid synthesis | PHYSIOL-L2R (biosynthetic direction) |
| 3-OXOACYL-ACP-REDUCT-RXN | Phospholipid synthesis | PHYSIOL-R2L (avoid NADPH-generating cycle) |
| RXN0-6705 | Phospholipid synthesis | PHYSIOL-R2L (avoid NADPH-generating cycle) |
| PHOSPHAGLYPSYN-RXN | Phospholipid synthesis | PHYSIOL-L2R (avoid NADPH-generating cycle) |
| H2PTERIDINEPYROPHOSPHOKIN-RXN | THF synthesis | PHYSIOL-L2R |
| RXN-9772 | NAD synthesis | PHYSIOL-L2R |
| RIBULP3EPIM-RXN | Pentose phosphate pathway | REVERSIBLE |
| RIB5PISOM-RXN | Pentose phosphate pathway | REVERSIBLE |
| 1TRANSKETO-RXN | Pentose phosphate pathway | REVERSIBLE |
| 2TRANSKETO-RXN | Pentose phosphate pathway | REVERSIBLE |
| TRANSALDOL-RXN | Pentose phosphate pathway | REVERSIBLE |
| PHOSACETYLTRANS-RXN | Central carbon metabolism | REVERSIBLE |
| RXN-12195 | Phosphorylation debugging | PHYSIOL-L2R |
| RXN-12196 | Phosphorylation debugging | PHYSIOL-L2R |
| XANPRIBOSYLTRAN-RXN | Phosphorylation debugging | PHYSIOL-R2L |
| DCTP-PYROPHOSPHATASE-RXN | Phosphorylation debugging | PHYSIOL-L2R |
| RXN-7913 | Phosphorylation debugging | PHYSIOL-L2R |
| ATPASE-RXN | Phosphorylation debugging | PHYSIOL-L2R |
| RXN0-5468 | Phosphorylation debugging | PHYSIOL-L2R |
| ALDHDEHYDROG-RXN | Phosphorylation debugging | PHYSIOL-L2R |